Zanamivir-13C,15N2 – 250 µg

Brand:
Cayman
CAS:
1276528-62-1
Storage:
-20
UN-No:
Non-Hazardous - /

Zanamivir-13C,15N2 is intended for use as an internal standard for the quantification of zanamivir (Item No. 15123) by GC- or LC-MS. Zanamivir is a sialic acid analog that inhibits neuraminidase release of newly replicated influenza virus particles.{24439} It has been shown to selectively inhibit the growth of influenza A and B viruses in plaque reduction assays with IC50 values ranging from 5 to 14 nM and to directly inhibit influenza A and B virus neuraminidases with IC50 values ranging from 0.6 to 7.9 nM in vitro. Intranasal zanamivir administration at 0.4 mg/kg twice daily reduces mortality and viral titers in lung homogenates of mice infected with influenza.  

 

Available on backorder

SKU: 30733 - 250 µg Category:

Description

An internal standard for the quantification of zanamivir by GC- or LC-MS


Formal name: 5-(acetylamino)-4-[(amino-15N-imino-15N-methyl-13C)amino]-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-ido-non-2-enonic acid

Synonyms: 

Molecular weight: 335.3

CAS: 1276528-62-1

Purity: ≥98%

Formulation: A solid